Evidence map›Paper›PMID 37872003›Full record

ArticleFEBS open bio2023

Low molecular weight chitosan oligosaccharides form stable complexes with human lactoferrin.

Juan Li, Shimin Guan, Baoguo Cai, Qianqian Li, Shaofeng Rong

Open access · goldAbstract read
In one paragraph

Article in FEBS open bio, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 75% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Juan LiDepartment of Bioengineering, School of Perfume and Aroma Technology, Shanghai Institute of Technology, Shanghai, China.
Shimin GuanDepartment of Bioengineering, School of Perfume and Aroma Technology, Shanghai Institute of Technology, Shanghai, China.
Baoguo CaiDepartment of Bioengineering, School of Perfume and Aroma Technology, Shanghai Institute of Technology, Shanghai, China.
Qianqian LiDepartment of Bioengineering, School of Perfume and Aroma Technology, Shanghai Institute of Technology, Shanghai, China.ORCID 0000-0002-4470-7214
Shaofeng RongDepartment of Bioengineering, School of Perfume and Aroma Technology, Shanghai Institute of Technology, Shanghai, China.
Shanghai Institute of Technology · CN

Funding

National Natural Science Foundation of China 31972165
6 · The paper itself

Abstract

Proteins in tears, including human lactoferrin (HLF), can be deposited and denatured on contact lenses, increasing the risk of microbial cell attachment to the lens and ocular complications. The surfactants currently used in commercial contact lens care solutions have low clearance ability for tear proteins. Chitosan oligosaccharide (COS) binds to a variety of proteins and has potential for use in protein removal, especially in contact lens care solutions. Here, we analyzed the interaction mechanism of COSs hydrolyzed from chitosan from different resources with HLF. The molecular weights (MWs) and concentrations of COSs were key factors for the formation of COS-HLF complexes. Lower MWs of COSs could form more stable COS-HLF complexes. COS from Aspergillus ochraceus had a superior effect on HLF compared with COS from shrimp and crab shell with the same MWs. In conclusion, COSs could bind to and cause a conformational change in HLF. Therefore, COSs, especially those with low MWs, have potential as deproteinizing agents in contact lens care solution.

Indexed as

ChitosanLactoferrinHumansMolecular WeightOligosaccharidesChitosanLactoferrinOligosaccharideschitosan oligosaccharidefluorescence quenchinghuman lactoferrininteractionmolecular dockingUV-Vis spectra

Identifiers

PMID37872003
PMCPMC10699096
OpenAlexW4387867445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.